Specific delivery of metronidazole using microparticles and thermosensitive in situ hydrogel for intrapocket administration as an alternative in periodontitis treatment
Nurul Muhlisah MaddeppungengNor Atikah SyahirahNasyrah HidayatiFadhlil U. A. RahmanKarima Qurnia MansjurIrene E. RieuwpassaDian SetiawatiMuhammad FadhlullahAnugerah Yaumil Ramadhani AzizAzimah SalsabilaAhmad R. AlsayedBoonnada PamornpathomkulAndi Dian PermanaRafikah Hasyima Department of Pharmacy,Faculty of Medicine and Health Sciences,Alauddin Islamic State University,Samata Gowa,Indonesiab Faculty of Pharmacy,Hasanuddin University,Makassar,Indonesiac Department of Orthodontic,Faculty of Dentistry,Hasanuddin University,Makassar,Indonesiad Department of Oral and Maxillofacial Radiology,Faculty of Dentistry,Hasanuddin University,Makassar,Indonesiae Department of Oral Biology,Faculty of Dentistry,Hasanuddin University,Makassar,Indonesiaf Department of Periodontology,Faculty of Dentistry,Hasanuddin University,Makassar,Indonesiag Veterinary Paramedic Study Program,Faculty of Vocational Study,Hasanuddin University,Makassar,Indonesiah Department of Clinical Pharmacy and Therapeutics,Applied Science Private University,Amman,Jordani Faculty of Pharmacy,Silpakorn University,Nakhon Pathom,Thailand
DOI: https://doi.org/10.1080/09205063.2024.2349414
2024-05-22
Journal of Biomaterials Science Polymer Edition
Abstract:Periodontitis is a common chronic inflammatory disease primarily caused by the prevalence of bacterial overgrowth resulting in the development of an inflammatory condition that destroys the tooth's supporting tissues and eventual tooth loss. Comparatively, to other treatment methods, it is difficult for topical antibacterial drugs to effectively permeate the biofilm's physical barrier, making conventional therapy for periodontitis more challenging. This novel study combines thermosensitive in situ hydrogel with microparticles (MPs) to enhance the targeted delivery of metronidazole (MET) to the periodontal pocket. Polycaprolactone (PCL) polymer was utilized to produce bacteria-sensitive MPs. Additionally, the study assessed the attributes of MPs and demonstrated an enhancement in the in vitro antibacterial efficacy of MPs towards Staphylococcus aureus (SA) and Escherichia coli (EC). Subsequently, we incorporated MET-MPs into thermosensitive in situ hydrogel formulations using chitosan. The optimized formulations exhibited stability, appropriate gelation temperature, mucoadhesive strength, and viscosity. In vitro permeation tests showed selective and prolonged drug release against SA and EC. Ex vivo experiments demonstrated no significant differences between in situ hydrogel containing pure MET and MET–MPs in biofilm quantity, bacterial counts, and metabolic activity in biofilms. According to in vitro tests and the effectiveness of the antibacterial activity, this study has exhibited a novel methodology for more efficacious therapies for periodontitis. This study aims to utilize MET in MPs to improve its effectiveness, enhance its antibacterial activity, and improve patient treatment outcomes. In further research, the efficacy of the treatment should be investigated in vivo using an appropriate animal model.
engineering, biomedical,materials science, biomaterials,polymer science